Investors / Luxembourg / Vesalius Biocapital Partners
Vesalius Biocapital Partners
Venture capital · Strassen, Luxembourg · Europe
Vesalius Biocapital Partners is a venture capital firm that invests in young European innovative life science companies active in human health. It has raised venture capital funds since 2007, has contributed to developing 20 companies, and manages more than €150 million across two funds.
Invests inHealthcare & Biotech
In its own wordslife sciencestherapeuticsmedical devicesdiagnosticshealthcareeurope
Your fit with Vesalius Biocapital Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsVesalius Biocapital Partners lists 10 checked portfolio companies on its own site and is named in 3 funding rounds, 2 of them as lead. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (90%) and Food & Agriculture (10%). It invests most often alongside Angelini Ventures, Beta Capital and BioGeneration Ventures.
Counts come from funding rounds that name Vesalius Biocapital Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Vesalius Biocapital Partners' whole history. Rounds on record name 3 companies; its own site lists 10. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 1 |
| '25 | 1 | 1 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 23th | 10 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 95th | 90% in its largest sector |
| Reach | 88th | 7 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Angelini Ventures | 1 |
| Beta Capital | 1 |
| BioGeneration Ventures | 1 |
| Cleverage VC | 1 |
| Debiopharm Innovation Fund | 1 |
| Eisai Innovation Inc. | 1 |
| Elaia | 1 |
| Epidarex | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers990%
- No longer answers00%
- Points to another company110%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 90% | 15% |
| Food & Agriculture | 10% | 3% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Angelini Ventures
Compare Vesalius Biocapital Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with Vesalius Biocapital Partners| Date | Company | Stage |
|---|---|---|
| 6 Oct 2026 | Series A | |
| 16 Sept 2025 | Series A Led | |
| 6 May 2024 | Series A Led |
Round details for Vesalius Biocapital Partners
Amounts, full round histories and every co-investor in Vesalius Biocapital Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Bienca develops solutions for the microbial safety of food products | Food & Agriculture | Portfolio page | ||
| Complix is a biopharmaceutical company developing a pipeline of transformative Cell Penetrating Alphabody based biotherapeutics | Healthcare & Biotech | Portfolio page | ||
| Exact Imaging develops and provides micro-ultrasound technology for urologic imaging and biopsy | Healthcare & Biotech | Portfolio page | ||
| Genomic Vision develops proprietary technology for bioproduction, gene and cell therapy, and the discovery of new molecules | Healthcare & Biotech | Portfolio page | ||
| Humedics develops and provides the LiMAx test, a liver function test used in liver surgery, transplantation, hepatology, and oncology. | Healthcare & Biotech | Portfolio page | ||
| inHEART develops and provides a digital twin of the heart for image-guided ablations | Healthcare & Biotech | May 2024Series A | Funding round | |
| Nutrium provides employee nutrition and benefits software for companies | Healthcare & Biotech | Sept 2025Series A | Funding round | |
| Omeicos Therapeutics is focused on developing therapies for cardiovascular, inflammatory and mitochondrial diseases | Healthcare & Biotech | Portfolio page | ||
| RougeTx is developing small-molecule therapies to restore vascular stability in diseases driven by pericyte dysfunction | Healthcare & Biotech | Oct 2026Series A | Funding round | |
Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- vesaliusbiocapital.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 6 May 2024
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Vesalius Biocapital Partners' profile as data
Pull Vesalius Biocapital Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/vesaliusbiocapital.com
# also
GET /v1/firms/vesaliusbiocapital.com/portfolio
GET /v1/firms/vesaliusbiocapital.com/coinvestors
GET /v1/firms/vesaliusbiocapital.com/news